Liquid chromatography-mass spectrometric assay for the quantitation in human plasma of ABT-888, an orally available, small molecule inhibitor of poly(ADP-ribose) polymerase

Por Parise, Robert A., Shawaqfeh, Mohammad, Egorin, Merrill J., Beumer, Jan H.
Publicado em 2008

Phase II AIDS Malignancy Consortium (AMC) trial of topical halofuginone in AIDS-associated Kaposi’s sarcoma (KS): clinical and biological effects using a novel intra-patient contro...

Por Krown, Susan E, Fingleton, Barbara, Lee, Jeannette Y, Egorin, Merrill J, Koon, Henry B
Publicado em 2010

Embryonic Stem Cells Lacking the Epigenetic Regulator Cfp1 are Hypersensitive to DNA-Damaging Agents and Exhibit Decreased Ape1/Ref-1 Protein Expression and Endonuclease Activity

Por Tate, Courtney M., Fishel, Melissa L., Holleran, Julianne L., Egorin, Merrill J., Skalnik, David G.
Publicado em 2009

Phase II AIDS Malignancy Consortium (AMC) trial of imatinib in AIDS-associated Kaposi’s sarcoma (KS)

Por Koon, Henry B, Honda, Kord, Lee, Jeannette Y, Christner, Susan M, Egorin, Merrill J, Noy, Ariela
Publicado em 2010

A High-Performance Liquid Chromatography-Mass Spectrometry Assay for Quantitation of the Tyrosine Kinase Inhibitor Nilotinib in Human Plasma and Serum

Por Parise, Robert A., Egorin, Merrill J., Christner, Susan M., Shah, Dhvani D., Zhou, Wei, Beumer, Jan H.
Publicado em 2009

Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc–Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice

Por Guo, Jianxia, Parise, Robert A., Joseph, Erin, Egorin, Merrill J., Lazo, John S., Prochownik, Edward V., Eiseman, Julie L.
Publicado em 2008

Formation of active products of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) in human blood and plasma and their activity against renal cell carcinoma lines

Por Parise, Robert A., Anyang, Bean N., Eiseman, Julie L., Egorin, Merrill J., Covey, Joseph M., Beumer, Jan H.
Publicado em 2012

Effect of antacid on imatinib absorption

Por Sparano, Brian A., Egorin, Merrill J., Parise, Robert A., Walters, Jennifer, Komazec, Kristin A., Redner, Robert L., Beumer, Jan H.
Publicado em 2008

Will Imatinib Compromise Reproductive Capacity?

Por Zamah, Alberuni M., Mauro, Michael J., Druker, Brian J., Oktay, Kutluk, Egorin, Merrill J., Cedars, Marcelle I., Rosen, Mitchell P.
Publicado em 2011

Enhancement of Cisplatin [cis-Diammine Dichloroplatinum (II)] Cytotoxicity by O(6)-Benzylguanine Involves Endoplasmic Reticulum Stress()

Por Rabik, Cara A., Fishel, Melissa L., Holleran, Julianne L., Kasza, Kristen, Kelley, Mark R., Egorin, Merrill J., Dolan, M. Eileen
Publicado em 2008

Characterization of the metabolism of benzaldehyde dimethane sulfonate (NSC 281612, DMS612)

Por Parise, Robert A., Eiseman, Julie L., Clausen, Dana M., Kicielinski, Kimberly P., Hershberger, Pamela A., Egorin, Merrill J., Beumer, Jan H.
Publicado no Cancer Chemother Pharmacol (2015)

Liquid chromatography-tandem mass spectrometric assay for the quantitation in human plasma of the novel indenoisoquinoline topoisomerase I inhibitors, NSC 743400 and NSC 725776

Por Holleran, Julianne L., Parise, Robert A., Yellow-Duke, Archibong E., Egorin, Merrill J., Eiseman, Julie L., Covey, Joseph M., Beumer, Jan H.
Publicado em 2010

In Vitro Cytotoxicity and In Vivo Efficacy, Pharmacokinetics, and Metabolism of 10074-G5, a Novel Small-Molecule Inhibitor of c-Myc/Max Dimerization

Por Clausen, Dana M., Guo, Jianxia, Parise, Robert A., Beumer, Jan H., Egorin, Merrill J., Lazo, John S., Prochownik, Edward V., Eiseman, Julie L.
Publicado em 2010

SAFETY, EFFICACY, PHARMACOKINETICS AND PHARMACODYNAMICS OF THE COMBINATION OF SORAFENIB AND TANESPIMYCIN

Por Vaishampayan, Ulka N., Burger, Angelika M., Sausville, Edward A., Heilbrun, Lance K., Li, Jing, Horiba, Naomi, Egorin, Merrill J., Ivy, Percy, Pacey, Simon, Lorusso, Patricia M.
Publicado em 2010

PHASE II AIDS MALIGNANCY CONSORTIUM TRIAL OF TOPICAL HALOFUGINONE IN AIDS-RELATED KAPOSI’S SARCOMA

Por Koon, Henry B., Fingleton, Barbara, Lee, Jeannette Y., Geyer, Julia T., Cesarman, Ethel, Parise, Robert A., Egorin, Merrill J., Dezube, Bruce J., Aboulafia, David, Krown, Susan E.
Publicado em 2011

Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma

Por Parise, Robert A., Beumer, Jan H., Kangani, Cyrous O., Holleran, Julianne L., Eiseman, Julie L., Smith, Nicola F., Covey, Joseph M., Perrine, Susan P., Egorin, Merrill J.
Publicado em 2007

Phase I Pharmacokinetic Study of the VEGFR Tyrosine Kinase Inhibitor Vatalanib (PTK787) plus Imatinib and Hydroxyurea for Malignant Glioma

Por Reardon, David A., Egorin, Merrill J., Desjardins, Annick, Vredenburgh, James J., Beumer, Jan H., Lagattuta, Theodore F., Gururangan, Sridharan, Herndon, James E., Salvado, August J., Friedman, Henry S.
Publicado em 2009

Effect of a proton pump inhibitor on the pharmacokinetics of imatinib

Por Egorin, Merrill J, Shah, Dhvani D, Christner, Susan M, Yerk, Mara A, Komazec, Kristin A, Appleman, Leonard R, Redner, Robert L, Miller, Brian M, Beumer, Jan H
Publicado em 2009

Phase I Pharmacokinetic and Pharmacodynamic Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an Inhibitor of Heat-Shock Protein 90, in Patients With Advanced Solid Tum...

Por Ramanathan, Ramesh K., Egorin, Merrill J., Erlichman, Charles, Remick, Scot C., Ramalingam, Suresh S., Naret, Cynthia, Holleran, Julianne L., TenEyck, Cynthia J., Ivy, S. Percy, Belani, Chandra P.
Publicado em 2010

In Vitro Circuit Stability of 5-Fluorouracil and Oxaliplatin in Support of Hyperthermic Isolated Hepatic Perfusion

Por Colville, Heidi, Dzadony, Ryan, Kemp, Rebecca, Stewart, Stephen, Zeh, Herbert J., Bartlett, David L., Holleran, Julianne, Schombert, Kevin, Kosovec, Juliann E., Egorin, Merrill J., Beumer, Jan H.
Publicado em 2010